About The Joint Corp.
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Hospitals
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: JYNT
- Previous Close: $3.83
- 50 Day Moving Average: $3.45
- 200 Day Moving Average: $2.68
- 52-Week Range: $1.85 - $4.74
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -12.35
- P/E Growth: -0.12
- Market Cap: $48.72M
- Outstanding Shares: 12,720,000
- Beta: 1.39
- Net Margins: -69.13%
- Return on Equity: -78.74%
- Return on Assets: -46.78%
Companies Related to The Joint Corp.:
- Current Ratio: 1.39%
- Quick Ratio: 1.39%
What is The Joint Corp.'s stock symbol?
The Joint Corp. trades on the NASDAQ under the ticker symbol "JYNT."
Where is The Joint Corp.'s stock going? Where will The Joint Corp.'s stock price be in 2017?
2 brokerages have issued 1 year price objectives for The Joint Corp.'s shares. Their forecasts range from $5.00 to $5.00. On average, they expect The Joint Corp.'s stock price to reach $5.00 in the next twelve months.
When will The Joint Corp. announce their earnings?
The Joint Corp. is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.
Who owns The Joint Corp. stock?
The Joint Corp.'s stock is owned by many different of retail and institutional investors. Top institutional investors include Glenhill Advisors LLC (18.59%), Sanders Morris Harris LLC (16.33%), Bard Associates Inc. (0.54%) and Russell Investments Group Ltd. (0.53%). Company insiders that own The Joint Corp. stock include Bret Sanders, David M Orwasher, Francis T Joyce, Glenhill Advisors Llc, James H Amos Jr, John B Richards, Peter D Holt, Richard A Kerley, Ronald V Davella and Steve Colmar.
Who sold The Joint Corp. stock? Who is selling The Joint Corp. stock?
The Joint Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Glenhill Advisors LLC and Bard Associates Inc..
Who bought The Joint Corp. stock? Who is buying The Joint Corp. stock?
The Joint Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd.. Company insiders that have bought The Joint Corp. stock in the last two years include Bret Sanders, Francis T Joyce, Glenhill Advisors Llc, James H Amos Jr, John B Richards, Peter D Holt, Richard A Kerley, Ronald V Davella and Steve Colmar.
How do I buy The Joint Corp. stock?
Shares of The Joint Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of The Joint Corp. stock cost?
One share of The Joint Corp. stock can currently be purchased for approximately $3.83.